First Horizon Corporation’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Sell
1,506
-160
-10% -$30.1K 0.01% 377
2026
Q1
$329K Buy
1,666
+447
+37% +$86.2K 0.01% 348
2025
Q4
$224K Buy
1,219
+330
+37% +$57.9K 0.01% 396
2025
Q3
$136K Buy
+889
New +$135K 0.01% 448
2013
Q2
$43K Buy
+900
New +$45.8K 0.01% 347

Other funds holding AZN

First Horizon Corporation's AZN Position: Q2 2026 in Review

First Horizon Corporation reduced its AstraZeneca (AZN) stake by 9.6% in Q2 2026, selling an estimated $30.1K and leaving 1,506 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #377.

First Horizon Corporation first reported a position in AZN in Q2 2013 and has held it in 5 quarters since. The position peaked at $329K in Q1 2026. 657 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • First Horizon Corporation held 1,506 shares of AstraZeneca worth $286K as of Q2 2026.
  • First Horizon Corporation sold 160 AstraZeneca shares in Q2 2026, an estimated $30.1K.
  • AstraZeneca made up 0.01% of First Horizon Corporation's portfolio in Q2 2026, its #377 holding.
  • First Horizon Corporation first reported a position in AstraZeneca in Q2 2013 and has held it in 5 quarters since.
  • First Horizon Corporation's AstraZeneca position peaked at $329K in Q1 2026.
  • 657 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.